Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will lead Resmed’s global investor relations function and report to Mick Farrell, CEO. Schwartz joins Resmed from Illumina, where she served as the Head of Investor Relations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMD:
- ResMed price target lowered to $268 from $280 at KeyBanc
- RMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- ResMed price target lowered to $265 from $280 at Mizuho
- Resmed’s Strong Financial Performance and Strategic Growth Drive Buy Rating
- Positive Outlook for Resmed Inc: Buy Rating Despite Short-Term Challenges